title: Neuroprotective properties of 5-HT1A receptor agonists in rodent models of focal and global cerebral ischemia.
abstract: 5-Hydroxytryptamine1A (5-HT1A) receptor agonists have been shown to inhibit the activity of hippocampal, cortical, and dorsal raphé neurons. We tested urapidil and a new 5-HT1A agonist, CM 57493 [4-(3-trifluoromethylphenyl)-1-(2-cyanoethyl)-1,2,3,6-tetrahydropyridine ], for their neuroprotective activity in models of focal and global cerebral ischemia in rodents. After middle cerebral artery-occlusion (MCA-0) in mice, the infarct size was reduced dose dependently by both urapidil and CM 57493. In MCA-occluded rats, CM 57493 (1 and 5 mg/kg) reduced the cortical infarct volume by 30% and application of 10 mg/kg CM 57493 led to a 40% reduction in the cortical infarct volume. The striatal damage could not be influenced by CM 57493 treatment. Furthermore, 1 and 5 mg/kg CM 57493 significantly reduced the neuronal damage within the CA1 sector of the rat hippocampus after 10 min of forebrain ischemia followed by 7 days of recovery. Measurement of cerebral and rectal temperature revealed that the neuroprotective effect of CM 57493 was not caused by a hypothermic effect. We assume that the neuroprotective activity of 5-HT1A agonists is mediated by an inhibitory action on neurons.
authors.affiliation: Institut für Pharmakologie und Toxikologie, Fachbereich Pharmazie und Lebensmittelchemie, Marburg, F.R.G.
authors.forename: J H
authors.initials: JH
authors.lastname: Prehn
authors.forename: C
authors.initials: C
authors.lastname: Backhauss
authors.forename: C
authors.initials: C
authors.lastname: Karkoutly
authors.forename: J
authors.initials: J
authors.lastname: Nuglisch
authors.forename: B
authors.initials: B
authors.lastname: Peruche
authors.forename: C
authors.initials: C
authors.lastname: Rossberg
authors.forename: J
authors.initials: J
authors.lastname: Krieglstein
mesh_terms: D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000098:blood supply / Q000187:drug effects; D002545:Brain Ischemia / Q000517:prevention & control*; D004195:Disease Models, Animal; D007034:Hypothalamus, Posterior / Q000098:blood supply / Q000187:drug effects / Q000473:pathology; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D008297:Male; D051379:Mice; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors; D010622:Phencyclidine / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin / Q000502:physiology*
chemical_list: D011725:Pyridines; D011985:Receptors, Serotonin; D016202:N-Methylaspartate; C045604:CM 57493; D010622:Phencyclidine